Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 12/20 | 0.52 |
| ▸ | PRSS1 | P07477 | 12/20 | 0.52 |
| ▸ | PLAT | P00750 | 11/20 | 0.52 |
| ▸ | PRSS2 | P07478 | 9/20 | 0.52 |
| ▸ | PRSS3 | P35030 | 9/20 | 0.52 |
| ▸ | KLKB1 | P03952 | 7/20 | 0.52 |
| ▸ | F2 | P00734 | 11/20 | 0.49 |
| ▸ | F10 | P00742 | 10/20 | 0.49 |
| ▸ | PLG | P00747 | 6/20 | 0.49 |
| ▸ | HPN | P05981 | 3/20 | 0.49 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.49 |
| ▸ | F7 | P08709 | 6/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28417878 | 0.80 | KDR (0.49) | KDM4EMEN1ALDH1A1MAPTHPGD | |
| SCHEMBL29429330 | 0.77 | F2 (0.59) | PLAUPRSS1PLATPRSS2PRSS3 | |
| SCHEMBL419839 | 0.77 | F2 (0.59) | PLAUPRSS1PLATPRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL688900 | 0.76 | F2 (0.58) | PLAUPRSS1PLATPRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL29614824 | 0.76 | F2 (0.58) | PLAUPRSS1PLATPRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL29692564 | 0.76 | F2 (0.58) | PLAUPRSS1PLATPRSS2PRSS3 | |
| Hydrochloric Acid SCHEMBL1256806 | 0.76 | F2 (0.58) | PLAUPRSS1PLATPRSS2PRSS3 | |
| SCHEMBL2860216 | 0.76 | KDR (0.54) | PLAUPRSS1PLATPRSS2PRSS3 | |
| SCHEMBL31310116 | 0.76 | KDR (0.54) | PLAUPRSS1PLATPRSS2PRSS3 | |
| SCHEMBL29481126 | 0.75 | KDR (0.50) | KDM4EMEN1ALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120118993-A | Application of MIF as target in preparation of medicine for monitoring or treating ischemic white matter injury | 华中科技大学同济医学院附属同济医院 | 2025-06-10 | — | — | CN | disclosed |
| CN-119971151-A | Myocardial tissue construct with bionic structure and function, and preparation method and application thereof | 中国科学院上海硅酸盐研究所 | 2025-05-13 | — | — | CN | disclosed |
| CN-119925711-A | Pre-neuronized cell patch capable of promoting myocardial tissue repair after myocardial infarction through nerve regulation and preparation method and application thereof | 中国科学院上海硅酸盐研究所 | 2025-05-06 | — | — | CN | disclosed |
| CN-119345165-A | Anti-glycation application of osmunda japonica ketone | 上海家化联合股份有限公司 | 2025-01-24 | — | — | CN | disclosed |
| CN-118806771-A | Application of tripterine in preparation of medicine for resisting diabetic nephropathy podocyte injury | 上海市普陀区中心医院 | 2024-10-22 | — | — | CN | disclosed |
| CN-118161520-A | Lipolytic composition using surface-modified gas-generating nanoparticles | 超新星生物有限公司 | 2024-06-11 | — | — | CN | disclosed |
| CN-114807108-B | Living cell surface functionalization based on dopamine polymerization and application | 上海交通大学医学院附属仁济医院 | 2024-04-02 | — | — | CN | disclosed |
| CN-114828834-B | Lipolytic composition using surface-modified gas-generating nanoparticles | 超新星生物有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117230010-A | Method for constructing in-vitro three-dimensional tumor model and application | 安徽中医药大学 | 2023-12-15 | — | — | CN | disclosed |
| CN-116964070-A | Peptide inhibitors of human mitochondrial fission protein 1 and methods of use | 威斯康星州医药大学股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-5654432-A | NAPHTHYLISOQUINOLINE ALKALOID ISOLATED FROM ANCISTROCLADUS SP. NOVUM VIA ORGANIC SOLVENT EXTRACTION, ACID-BASE PARTITIONING, CENTRIFUGAL PARTITION CHROMATOGRAPHY, AND HPLC USING AN AMINO-BONDED PHASE COLUMN; VIRICIDE | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1997-08-05 | — | — | US | disclosed |
| EP-0695294-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-07 | — | — | EP | disclosed |
| US-5455251-A | Treatment of AIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1995-10-03 | — | — | US | disclosed |
| WO-1994024108-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-27 | — | — | WO | disclosed |
| EP-0594795-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1994-05-04 | — | — | EP | disclosed |
| EP-0594795-A4 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT. | US SECRETARY UNITED STATES DEP (US) | 1993-12-07 | — | — | EP | disclosed |
| EP-0527774-A4 | CALCITONIN GENE RELATED PEPTIDE FOR THE TREATMENT OF UNDESCENDED TESTICLES | — | 1993-03-31 | — | — | EP | disclosed |
| EP-0527774-A1 | CALCITONIN GENE RELATED PEPTIDE FOR THE TREATMENT OF UNDESCENDED TESTICLES | THE UNIVERSITY OF MELBOURNE (AU) | 1993-02-24 | — | — | EP | disclosed |
| WO-1992018125-A1 | MICHELLAMINES USEFUL AS ANTIVIRAL AGENTS, COMPOSITION AND METHOD OF TREATMENT | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, U.S. DEPARTMENT OF COMMERCE (US) | 1992-10-29 | — | — | WO | disclosed |
| WO-1991015246-A1 | CALCITONIN GENE RELATED PEPTIDE FOR THE TREATMENT OF UNDESCENDED TESTICLES | THE UNIVERSITY OF MELBOURNE (AU) | 1991-10-17 | — | — | WO | disclosed |